So, Lorlatinib is this fancy third-generation inhibitor that goes after those ALK and ROS1 kinases. It comes in tablet form, with doses of 25 mg and 100 mg. You’re supposed to take just one 100 mg tablet each day, whether you eat or not.
Each bottle holds 30 tablets. It’s mainly used for treating ALK-positive lung cancer that’s spread to other parts of the body, especially in people who didn’t get better or whose cancer got worse after trying other ALK inhibitors.
